Cell-Membrane Coated Nanoparticles for Tumor Delineation and Qualitative Estimation of Cancer Biomarkers at Single Wavelength Excitation in Murine and Phantom Models
Source abstract
Abstract
Real-time guidance through fluorescence imaging improves the surgical outcomes of tumor resections, reducing the chances of leaving positive margins behind. As tumors are heterogeneous, it is imperative to interrogate multiple overexpressed cancer biomarkers with high sensitivity and specificity to improve surgical outcomes. However, for accurate tumor delineation and ratiometric detection of tumor biomarkers, current methods require multiple excitation wavelengths to image multiple biomarkers, which is impractical in a clinical setting. Here, we have developed a biomimetic platform comprising near-infrared fluorescent semiconducting polymer nanoparticles (SPNs) with red blood cell membrane (RBC) coating, capable of targeting two representative cell-surface biomarkers (folate, αυβ3 integrins) using a single excitation wavelength for tumor delineation during surgical interventions. We evaluate our single excitation ratiometric nanoparticles in in vitro tumor cells, ex vivo tumor-mimicking phantoms, and in vivo mouse xenograft tumor models. Favorable biological properties (improved biocompatibility, prolonged blood circulation, reduced liver uptake) are complemented by superior spectral features: (i) specific fluorescence enhancement in tumor regions with high tumor-to-normal tissue (T/NT) ratios in ex vivo samples and (ii) estimation of cell-surface tumor biomarkers with single wavelength excitation providing insights about cancer progression (metastases). Our single excitation, dual output approach has the potential to differentiate between the tumor and healthy regions and simultaneously provide a qualitative indicator of cancer progression, thereby guiding surgeons in the operating room with the resection process.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photoacoustic and Ultrasonic Imaging · Cancer Research and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Cell Biology, Duke University, Durham, North Carolina 27705, United States
Funding
National Cancer Institute · Division of Molecular and Cellular Biosciences · Congressionally Directed Medical Research Programs · Division of Chemical, Bioengineering, Environmental, and Transport Systems
References (64)
Show source-provided references
1. 10.1016/j.clbc.2018.04.00410.1016/j.clbc.2018.04.004 ↗
2. 10.3390/cancers1317428710.3390/cancers13174287 ↗
3. 10.3322/caac.2170810.3322/caac.21708 ↗
4. 10.1200/JCO.2007.14.306510.1200/JCO.2007.14.3065 ↗
5. 10.1016/j.cbpa.2018.03.00210.1016/j.cbpa.2018.03.002 ↗
6. 10.1038/nrclinonc.2013.12310.1038/nrclinonc.2013.123 ↗
7. 10.1002/jso.2510510.1002/jso.25105 ↗
8. 10.1002/cncr.2879310.1002/cncr.28793 ↗
9. 10.1002/jso.2416710.1002/jso.24167 ↗
10. 10.1186/s12957-020-01874-z10.1186/s12957-020-01874-z ↗
11. 10.1016/j.jtcvs.2015.05.01410.1016/j.jtcvs.2015.05.014 ↗
12. 10.1117/12.254529210.1117/12.2545292 ↗
13. 10.1126/scitranslmed.aaw706710.1126/scitranslmed.aaw7067 ↗
14. 10.2147/IJN.S20748610.2147/IJN.S207486 ↗
15. 10.1117/1.JBO.23.10.10060110.1117/1.JBO.23.10.100601 ↗
16. 10.1038/s41551-016-001010.1038/s41551-016-0010 ↗
17. 10.1021/cr900263j10.1021/cr900263j ↗
18. 10.1371/journal.pone.019785710.1371/journal.pone.0197857 ↗
19. 10.1155/2012/94058510.1155/2012/940585 ↗
20. 10.1021/cr200263w10.1021/cr200263w ↗
21. 10.7150/thno.469010.7150/thno.4690 ↗
22. 10.1016/j.nano.2022.10258310.1016/j.nano.2022.102583 ↗
23. 10.1021/bc500567910.1021/bc5005679 ↗
24. 10.1021/bc049828r10.1021/bc049828r ↗
25. 10.1039/D2NA00276K10.1039/D2NA00276K ↗
26. 10.1002/anie.20120513310.1002/anie.201205133 ↗
27. 10.1016/j.biomaterials.2017.11.02510.1016/j.biomaterials.2017.11.025 ↗
28. 10.1021/acsnano.0c0561010.1021/acsnano.0c05610 ↗
29. 10.1002/anie.20170554310.1002/anie.201705543 ↗
30. 10.1039/C6SC01251E10.1039/C6SC01251E ↗
31. 10.1021/acsnano.6b0290810.1021/acsnano.6b02908 ↗
32. 10.1021/acsnano.7b0861610.1021/acsnano.7b08616 ↗
33. 10.1002/adma.20170675910.1002/adma.201706759 ↗
34. 10.1002/adma.20150332310.1002/adma.201503323 ↗
35. 10.1021/acsnano.7b0904110.1021/acsnano.7b09041 ↗
36. 10.1002/adma.20170493410.1002/adma.201704934 ↗
37. 10.1126/sciadv.aay903510.1126/sciadv.aay9035 ↗
38. 10.1021/acsnano.2c0106210.1021/acsnano.2c01062 ↗
39. 10.1021/acsnano.0c0382410.1021/acsnano.0c03824 ↗
40. 10.1002/adma.20190509110.1002/adma.201905091 ↗
41. 10.1021/acsnano.8b0406610.1021/acsnano.8b04066 ↗
42. 10.1038/s41551-022-00902-510.1038/s41551-022-00902-5 ↗
43. 10.1021/ac401377n10.1021/ac401377n ↗
44. 10.1021/acsnano.5b0155210.1021/acsnano.5b01552 ↗
45. 10.1021/acsnano.2c0089310.1021/acsnano.2c00893 ↗
46. 10.1021/acsnano.1c0068010.1021/acsnano.1c00680 ↗
47. 10.1021/acsnano.2c0032010.1021/acsnano.2c00320 ↗
48. 10.1021/acsnano.1c0981810.1021/acsnano.1c09818 ↗
49. 10.1186/2191-219X-3-2110.1186/2191-219X-3-21 ↗
50. 10.1016/j.athoracsur.2017.08.06210.1016/j.athoracsur.2017.08.062 ↗
51. 10.1016/j.ygyno.2019.07.01010.1016/j.ygyno.2019.07.010 ↗
52. 10.1200/JCO.2010.33.888910.1200/JCO.2010.33.8889 ↗
53. 10.1126/scitranslmed.aaw706710.1126/scitranslmed.aaw7067 ↗
54. 10.1016/j.nano.2017.07.01310.1016/j.nano.2017.07.013 ↗
55. 10.1002/mrm.2701610.1002/mrm.27016 ↗
56. 10.3791/5177610.3791/51776 ↗
57. 10.1002/smll.20180175410.1002/smll.201801754 ↗
58. 10.1002/smll.20180300210.1002/smll.201803002 ↗
59. 10.1021/acsnano.0c0313110.1021/acsnano.0c03131 ↗
60. 10.1021/acsnano.2c0592310.1021/acsnano.2c05923 ↗
61. 10.1021/acsnano.8b0655610.1021/acsnano.8b06556 ↗
62. 10.1117/12.257853410.1117/12.2578534 ↗
63. 10.1117/1.JBO.27.9.09600610.1117/1.JBO.27.9.096006 ↗
64. 10.1364/OE.45810110.1364/OE.458101 ↗